26
CHEMISTRY & BIODIVERSITY – Vol. 6 (2009)
2 HꢀC(3)); 1.75 (dd, J¼6.8, J¼1.9, 3 HꢀC(8)). 13C-NMR (100 MHz, CDCl3): 172.4 (s, C(1)); 138.7 (d,
C(7)); 110.7 (d, C(6)); 86.0 (s, C(4)); 79.8 (s, C(5)); 51.7 (q, MeO); 33.5 (t, C(2)); 18.4 (t, C(3)); 15.2 (q,
C(8)). EI-MS (70 eV): 152 (17, Mþ ), 137 (18), 124 (59), 121 (21), 109 (100), 91 (89), 79 (46), 77 (92), 74
(6), 65 (27), 63 (19), 59 (12), 53 (20), 51 (29), 41 (13), 39 (33).
(Z)-Methyl Oct-6-en-4-ynoate (10). Yield: 0.56 g (91%). 1H-NMR (400 MHz, CDCl3): 5.91 (dq, J¼
10.6, J¼6.8, HꢀC(7)); 5.43 (dq, J¼10.6, J¼1.9, HꢀC(6)); 3.70 (s, MeO); 2.76–2.52 (m, 2 HꢀC(2),
2 HꢀC(3)); 1.83 (dd, J¼6.8, J¼1.7, 3 HꢀC(8)). 13C-NMR (100 MHz, CDCl3): 172.4 (s, C(1)); 137.6 (d,
C(7)); 110.0 (d, C(6)); 92.4 (s, C(4)); 77.8 (s, C(5)); 51.7 (q, MeO); 33.6 (t, C(2)); 15.6 (q, C(8)); 15.4 (t,
C(3)). EI-MS (70 eV): 152 (42, Mþ ), 137 (22), 124 (64), 121 (22), 109 (100), 91 (92), 79 (53), 77 (91), 74
(7), 65 (31), 63 (22), 59 (12), 53 (22), 51 (31), 41 (13), 39 (34).
Preparation of Methyl Octadienoates and Methyl Decadienoate. The dienoates 11, 12, and 26 were
prepared by hydrogenation of compound 9, 10, and 25, resp., using P-2 nickel as catalyst, according to a
procedure of Brown et al. [17]. The freshly prepared catalyst (1.0 equiv.) was placed under H2.
Ethylenediamine (2.0 equiv.), and the ester 9, 10, or 25 (8.0 equiv. based on the number of triple bonds),
resp., were added consecutively. The mixture was filtered after completion of the reaction, diluted with
H2O, and extracted with Et2O. The combined org. layers were washed with H2O, dried (MgSO4), and the
solvent was removed. Purification of the raw products by CC (SiO2; pentane/Et2O 19 :1) afforded pure
11, 12, or 26, resp., as colorless liquids.
Methyl (4Z,6E)-Octa-4,6-dienoate (11). Yield: 87 mg (20%). 1H-NMR (400 MHz, CDCl3): 6.37–
6.29 (m, HꢀC(6)); 6.04–5.95 (m, HꢀC(5)); 5.75–5.66 (HꢀC(7)); 5.28–5.21 (m, HꢀC(4)); 3.67 (s,
MeO); 2.52–2.46 (m, 2 HꢀC(3)); 2.42–2.36 (m, 2 HꢀC(2)); 1.78 (dd, 3J¼6.8, 4J¼1.6, 3 HꢀC(8)).
13C-NMR (100 MHz, CDCl3): 173.5 (s, C(1)); 130.2 (d, C(7)); 129.9 (d, C(5)); 126.7 (d, C(4)); 126.6 (d,
C(6)); 51.5 (q, MeO); 34.1 (t, C(2)); 23.2 (t, C(3)); 18.3 (q, C(8)). EI-MS (70 eV): 154 (54, Mþ ), 123
(13), 111 (4), 94 (79), 81 (75), 79 (100), 74 (7), 67 (27), 59 (10), 55 (21), 53 (26), 41 (31), 39 (31).
1
Methyl (4Z,6Z)-Octa-4,6-dienoate (12). Yield: 225 mg (52%). H-NMR (400 MHz, CDCl3): 6.41–
6.24 (m, HꢀC(5), HꢀC(6)); 5.62–5.52 (m, HꢀC(7)); 5.46–5.37 (m, HꢀC(4)); 3.67 (s, MeO); 2.53–2.46
3
4
(m, 2 HꢀC(3)); 2.43–2.36 (m, 2 HꢀC(2)); 1.75 (dd, J¼6.7, J¼1.7, 3 HꢀC(8)). 13C-NMR (100 MHz,
CDCl3): 173.4 (s, C(1)); 128.8 (d, C(4)); 127.0 (d, C(7)); 124.6 (d, C(5)); 124.0 (d, C(6)); 51.5 (q, MeO);
34.0 (t, C(2)); 23.0 (t, C(3)); 13.1 (q, C(8)). EI-MS (70 eV): 154 (41, Mþ ), 123 (10), 111 (3), 94 (74), 81
(67), 79 (100), 74 (6), 67 (25), 59 (10), 55 (20), 53 (25), 41 (30), 39 (31).
1
Methyl (4Z,7Z)-Deca-4,7-dienoate (26). Yield: 0.05 g (20%). H-NMR (400 MHz, CDCl3): 5.44–
5.26 (m, HꢀC(4), HꢀC(5), HꢀC(7), HꢀC(8)); 3.68 (s, MeO); 2.80 (t, J¼7.0, 2 HꢀC(6)); 2.43–2.29
(m, 2 HꢀC(2), 2 HꢀC(3)); 2.11–2.01 (m, 2 HꢀC(9)); 0.97 (t, J¼7.5, 3 HꢀC(10)). 13C-NMR (100 MHz,
CDCl3): 173.6 (s, C(1)); 132.1 (d); 129.7 (d); 127.5 (d); 126.9 (d); 51.5 (q, MeO); 34.0 (t, C(2)); 25.4 (t);
22.7 (t); 20.5 (t); 14.2 (q, C(10)). EI-MS (70 eV): 182 (2, Mþ ), 150 (32), 122 (6), 108 (43), 93 (38), 79
(100), 74 (5), 67 (10), 59 (15), 55 (23), 41 (39), 39 (31).
(tert-Butyl)(dimethyl)(pent-4-ynyloxy)silane (14). According to the method of Akita et al. [18], a
soln. of pent-4-yn-1-ol (13; 2.94 g, 35.00 mmol), 1H-imidazole (4.92 g, 71.00 mmol), and TBDMSCl
(7.97 g, 53.00 mmol) in abs. DMF (20 ml) was stirred at r.t. for 1 h. After addition of brine, the mixture
was extracted with AcOEt/hexane 1:1. The combined org. layers were washed with brine, dried
(MgSO4), and the solvent was removed. Purification of the residue by CC (SiO2; pentane/Et2O 30 :1)
furnished pure 14 (5.11 g, 74%). Colorless liquid. 1H-NMR (400 MHz, CDCl3): 3.70 (t, J¼6.0,
2 HꢀC(1)); 2.27 (dt, 3J¼7.1, 4J¼2.6, 2 HꢀC(3)); 1.92 (t, 4J¼2.7, HꢀC(5)); 1.72 (tt, J¼6.1, J¼7.1,
2 HꢀC(2)); 0.90 (s, t-Bu); 0.06 (s, 2 Me). 13C-NMR (100 MHz, CDCl3): 84.2 (s, C(4)); 68.2 (d, C(5)); 61.4
(t, C(1)); 31.5 (t, C(2)); 25.9 (q, Me3C); 18.3 (s, Me3C); 14.8 (t, C(3)); ꢀ5.4 (q, 2 Me). EI-MS (70 eV):
183 (1), 155 (3), 141 (100), 123 (3), 111 (29), 99 (8), 83 (10), 75 (85), 67 (3), 59 (12), 45 (9), 41 (9).
(tert-Butyl)(dimethyl)[(4E,6Z)-octa-4,6-dienyloxy]silane (15). The protected dienol 15 was pre-
pared from 14 in two steps by a modified published procedure [20]. Instead of (E)-1-bromoprop-1-ene,
1
the (Z)-isomer was used. Yield: 1.48 g (27%). H-NMR (400 MHz, CDCl3): 6.38–6.30 (m, HꢀC(5));
6.00–5.94 (m, HꢀC(6)); 5.66 (dt, J¼7.0, J¼15.1, HꢀC(4)); 5.37 (dq, J¼7.1, J¼10.7, HꢀC(7)); 3.62 (t,
J¼6.4, 2 HꢀC(1)); 2.20–2.14 (m, 2 HꢀC(3)); 1.73 (dd, 3J¼7.1, 4J¼1.7, 3 HꢀC(8)); 1.66–1.58 (m,
2 HꢀC(2)); 0.90 (s, t-Bu); 0.05 (s, 2 Me). 13C-NMR (100 MHz, CDCl3): 133.8 (d, C(4)); 129.5 (d, C(6));
125.7 (d, C(5)); 124.0 (d, C(7)); 62.5 (t, C(1)); 32.5 (t, C(2)); 29.1 (t, C(3)); 26.0 (q, Me3C); 18.3 (s, Me3C);